X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs ELDER PHARMA - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK ELDER PHARMA MERCK/
ELDER PHARMA
 
P/E (TTM) x 51.1 -0.2 - View Chart
P/BV x 7.7 0.1 7,604.0% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 MERCK   ELDER PHARMA
EQUITY SHARE DATA
    MERCK
Dec-17
ELDER PHARMA
Jun-14
MERCK/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs1,358380 357.2%   
Low Rs933188 496.3%   
Sales per share (Unadj.) Rs665.0491.2 135.4%  
Earnings per share (Unadj.) Rs56.6-3.2 -1,778.1%  
Cash flow per share (Unadj.) Rs72.514.4 503.0%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs441.7376.5 117.3%  
Shares outstanding (eoy) m16.6020.54 80.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.6 297.8%   
Avg P/E ratio x20.2-89.3 -22.7%  
P/CF ratio (eoy) x15.819.7 80.2%  
Price / Book Value ratio x2.60.8 343.7%  
Dividend payout %26.50-   
Avg Mkt Cap Rs m19,0115,833 325.9%   
No. of employees `0001.5NA-   
Total wages/salary Rs m1,6962,179 77.9%   
Avg. sales/employee Rs Th7,150.0NM-  
Avg. wages/employee Rs Th1,098.7NM-  
Avg. net profit/employee Rs Th608.2NM-  
INCOME DATA
Net Sales Rs m11,04010,089 109.4%  
Other income Rs m240257 93.4%   
Total revenues Rs m11,27910,346 109.0%   
Gross profit Rs m1,376-792 -173.8%  
Depreciation Rs m264361 73.1%   
Interest Rs m02,756 0.0%   
Profit before tax Rs m1,352-3,653 -37.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1703,713 4.6%   
Tax Rs m583125 465.7%   
Profit after tax Rs m939-65 -1,437.0%  
Gross profit margin %12.5-7.8 -158.8%  
Effective tax rate %43.1-3.4 -1,258.3%   
Net profit margin %8.5-0.6 -1,313.3%  
BALANCE SHEET DATA
Current assets Rs m7,5239,240 81.4%   
Current liabilities Rs m2,2539,998 22.5%   
Net working cap to sales %47.7-7.5 -635.7%  
Current ratio x3.30.9 361.4%  
Inventory Days Days5246 112.6%  
Debtors Days Days4160 67.7%  
Net fixed assets Rs m1,24010,124 12.2%   
Share capital Rs m166206 80.7%   
"Free" reserves Rs m7,1675,582 128.4%   
Net worth Rs m7,3337,734 94.8%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m9,91222,882 43.3%  
Interest coverage xNM-0.3-  
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.10.4 252.6%   
Return on assets %9.511.8 80.6%  
Return on equity %12.8-0.8 -1,515.6%  
Return on capital %20.822.3 93.0%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m1,015307 330.9%   
Fx outflow Rs m3,043125 2,428.3%   
Net fx Rs m-2,028181 -1,118.6%   
CASH FLOW
From Operations Rs m53711,754 4.6%  
From Investments Rs m-476-561 85.0%  
From Financial Activity Rs m-220-6,762 3.3%  
Net Cashflow Rs m-1604,432 -3.6%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 7.5 242.7%  
FIIs % 1.0 16.8 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 36.1 80.6%  
Shareholders   28,591 16,479 173.5%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare MERCK With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 425 Points Higher; Banking and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours and ended their day on a positive note. Gains were largely seen in the banking sector and energy sector.

Related Views on News

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Mar 26, 2019 03:35 PM

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS